Algernon Pharmaceuticals Stock Shares Owned By Institutions
AGNPF Stock | USD 0.05 0 2.99% |
Algernon Pharmaceuticals fundamentals help investors to digest information that contributes to Algernon Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Algernon OTC Stock. The fundamental analysis module provides a way to measure Algernon Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Algernon Pharmaceuticals otc stock.
Algernon |
Algernon Pharmaceuticals OTC Stock Shares Owned By Institutions Analysis
Algernon Pharmaceuticals' Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Algernon Pharmaceuticals Shares Owned By Institutions | 14.73 % |
Most of Algernon Pharmaceuticals' fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Algernon Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition |
Based on the latest financial disclosure, 14.73% of Algernon Pharmaceuticals are shares owned by institutions. This is 67.0% lower than that of the Healthcare sector and 68.99% lower than that of the Biotechnology industry. The shares owned by institutions for all United States stocks is 62.43% higher than that of the company.
Algernon Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Algernon Pharmaceuticals' direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Algernon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Algernon Pharmaceuticals by comparing valuation metrics of similar companies.Algernon Pharmaceuticals is currently under evaluation in shares owned by institutions category among its peers.
Algernon Fundamentals
Return On Equity | -1.09 | |||
Return On Asset | -0.53 | |||
Current Valuation | 3.03 M | |||
Shares Outstanding | 2.41 M | |||
Shares Owned By Insiders | 1.70 % | |||
Shares Owned By Institutions | 14.73 % | |||
Price To Book | 1.02 X | |||
EBITDA | (6.02 M) | |||
Net Income | (6.05 M) | |||
Cash And Equivalents | 872.84 K | |||
Cash Per Share | 0.44 X | |||
Current Ratio | 1.16 X | |||
Book Value Per Share | 1.86 X | |||
Cash Flow From Operations | (2.91 M) | |||
Earnings Per Share | (2.28) X | |||
Beta | 0.32 | |||
Market Capitalization | 3.96 M | |||
Total Asset | 8.14 M | |||
Net Asset | 8.14 M |
About Algernon Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Algernon Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Algernon Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Algernon Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Algernon OTC Stock
Algernon Pharmaceuticals financial ratios help investors to determine whether Algernon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Algernon with respect to the benefits of owning Algernon Pharmaceuticals security.